Literature DB >> 14612315

In vitro thermal therapy of AT-1 Dunning prostate tumours.

S Bhowmick1, J E Coad, D J Swanlund, J C Bischof.   

Abstract

To advance the utility of prostate thermal therapy, this study investigated the thermal thresholds (temperature-time) for prostate tissue destruction in vitro. The AT-1 Dunning prostate tumour model was chosen for the study. Three hundred micron thick sections were subjected to controlled temperature-time heating, which ranged from low (40 degrees C, 15 min) to high thermal exposures (70 degrees C, 2 min) (n = 6). After subsequent tissue culture at 37 degrees C, the sections were evaluated for tissue injury at 3, 24 and 72 h by two independent methods: histology and dye uptake. A graded increase in injury was identified between the low and high thermal exposures. Maximum histologic injury occurred above 70 degrees C, 1 min with >95% of the tissue area undergoing significant cell injury and coagulative necrosis. The control and 40 degrees C, 15 min sections showed histologic evidence of apoptosis following 24 and 72 h in culture. Similar signs of apoptosis were minimal or absent at higher thermal histories. Vital-dye uptake quantitatively confirmed complete cell death after 70 degrees C, 2 min. Using the dye data, Arrhenius analysis showed an apparent breakpoint at 50 degrees C, with activation energies of 135.8 kcal/mole below and 4.7 kcal/mole above the threshold after 3 h in culture. These results can be used as a conservative benchmark for thermal injury in the cancerous prostate. Further characterization of the response to thermal therapy in an animal model and in human tissues will be important in establishing the efficacy of the procedure

Entities:  

Mesh:

Year:  2004        PMID: 14612315     DOI: 10.1080/0265673031000111932

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  8 in total

1.  Nanoparticle delivered vascular disrupting agents (VDAs): use of TNF-alpha conjugated gold nanoparticles for multimodal cancer therapy.

Authors:  Mithun M Shenoi; Isabelle Iltis; Jeunghwan Choi; Nathan A Koonce; Gregory J Metzger; Robert J Griffin; John C Bischof
Journal:  Mol Pharm       Date:  2013-04-17       Impact factor: 4.939

2.  Spatiotemporal temperature distribution and cancer cell death in response to extracellular hyperthermia induced by gold nanorods.

Authors:  Huang-Chiao Huang; Kaushal Rege; Jeffrey J Heys
Journal:  ACS Nano       Date:  2010-05-25       Impact factor: 15.881

3.  Mapping of hyperthermic tumor cell death in a microchannel under unidirectional heating.

Authors:  Fen Wang; Yuhui Li; Lei Chen; Dandan Chen; Xiaolei Wu; Hao Wang
Journal:  Biomicrofluidics       Date:  2012-03-20       Impact factor: 2.800

4.  Evaluation of important treatment parameters in supraphysiological thermal therapy of human liver cancer HepG2 cells.

Authors:  Bhavik Shah; Sankha Bhowmick
Journal:  Ann Biomed Eng       Date:  2006-10-10       Impact factor: 3.934

5.  FEM numerical model analysis of magnetic nanoparticle tumor heating experiments.

Authors:  John A Pearce; Alicia A Petyk; P Jack Hoopes
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2014

Review 6.  Ablative therapies for small renal tumours.

Authors:  Arturo Castro; Lawrence C Jenkins; Nelson Salas; Gideon Lorber; Raymond J Leveillee
Journal:  Nat Rev Urol       Date:  2013-04-23       Impact factor: 14.432

7.  Thermostability of biological systems: fundamentals, challenges, and quantification.

Authors:  Xiaoming He
Journal:  Open Biomed Eng J       Date:  2011-04-12

8.  Thermal cycling as a novel thermal therapy to synergistically enhance the anticancer effect of propolis on PANC‑1 cells.

Authors:  Wei-Ting Chen; Yi-Kun Sun; Chueh-Hsuan Lu; Chih-Yu Chao
Journal:  Int J Oncol       Date:  2019-07-16       Impact factor: 5.650

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.